本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Anaptysbio Inc

23.75
-0.1300-0.54%
盘后23.60-0.1500-0.63%16:20 EDT
成交量:21.28万
成交额:507.28万
市值:6.98亿
市盈率:-4.96
高:24.13
开:23.65
低:23.51
收:23.88
数据加载中...
2024/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities